ANDA 62982, held by Ph Health. Ampicillin/Ampicillin Trihydrate.
As of Nov 16, 2026, ANDA 62982 (Ampicillin Trihydrate), held by Ph Health, was first approved by FDA on Feb 10, 1989, with 9 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 10, 1989 | Original application | Approved | None posted |
| Ampicillin TrihydrateEQ 125MG BASE/5ML · for suspension;oral | Ampicillin/Ampicillin Trihydrate | Discontinued |
| Ampicillin TrihydrateEQ 250MG BASE/5ML · for suspension;oral | Ampicillin/Ampicillin Trihydrate | Discontinued |
| May 1, 2024 | Supplement 16Labeling · Standard review | Approved | None posted |
| Sep 25, 2015 | Supplement 15Labeling · Standard review | Approved | None posted |
| Jan 26, 2001 | Supplement 9Manufacturing | Approved | None posted |
| Aug 20, 1996 | Supplement 8Labeling | Approved | None posted |
| Aug 20, 1996 | Supplement 7Labeling | Approved | None posted |
| Apr 26, 1996 | Supplement 5Manufacturing | Approved | None posted |
| Jun 1, 1994 | Supplement 4Labeling | Approved | None posted |
| Jun 1, 1994 | Supplement 3Manufacturing | Approved | None posted |
| Apr 27, 1993 | Supplement 1Labeling | Approved | None posted |
| Feb 10, 1989 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters